Trio-Tech's burn-in board orders keep accelerating, with another order for next-generation boards, and it ranks among the highest-conviction micro-caps to hold long term. Per @ren_stocks, it has won over $5 million of burn-in board orders this quarter, including $2.6 million for a next-generation AI GPU platform, on top of $5.3 million in March. Every AI GPU and CPU must pass burn-in testing before shipping; last quarter revenue rose 124% and back-end solutions 141%. x.com 

Trio-Tech is a high-conviction, high-risk asymmetric bet on burn-in testing demand for AI chips. Q3 revenue rose 124% to $16.5 million, new orders of $5.3 million and $2.6 million cover burn-in boards for next-gen AI GPUs, and a $10 million raise funds a Malaysia facility. At about $160 million it trades far below peers, with trailing EPS now positive. Risks: gross margin fell to 16% from 27%, dilution, insider selling, a run from $2.45 to $21.38 then a sharp pullback, and thin liquidity. x.com 

Trio-Tech's bear case has been validated: growth is slowing and margins are bad. The stock fell 30% on the quarter, which @JonkooTrades, a bull who admits defeats publicly, said he could not explain. x.com 

Trio-Tech's second order for the same next-gen AI GPU platform shows the customer's production ramp is real. A $2.6 million order follows $5.3 million in March, about $8 million for one program, and customers don't reorder if the first batch failed. Every AI GPU must be burned in under extreme heat, voltage and load before shipping, making its burn-in boards a quiet, mandatory chokepoint. The roughly $160 million micro-cap doubled nine-month revenue to $48 million and is expanding in Malaysia. … Show more

Trio-Tech is a risky but compelling micro-cap sitting in the middle of a burn-in testing bottleneck. Growth is huge year over year, potential new customers include Micron, and CPU demand should soar in the inference era while Trio-Tech handles burn-in testing for AMD. Real estate is roughly 10% of its market cap, and the multiple looks ridiculous if execution continues. @JonkooTrades notes Zacks just initiated the first Wall Street coverage, at Neutral, citing AI burn-in orders. x.com 

Trio-Tech's gross margins are deteriorating because its testing revenue carries lower margins than its legacy segments. @yianisz counters that Trio-Tech still looks obvious and its margins will recover over the next 2-3 quarters. x.com  x.com 

Burn-in test is one of three areas set to run hot into the summer, alongside CPU ecosystem names and power semis, driven by the Rubin ramp and the CPU production ramp. Trio-Tech and inTEST are among the undervalued names with immediate upside. inTEST has a third tailwind from the scale-up of power semis. Capital should shift from photonics and connectivity toward these areas. Barring a prolonged Strait of Hormuz closure, other headwinds such as private credit shouldn't hit until Q3 or later. … Show more

Aehr Test Systems' valuation looks ahead of its fundamentals after a strong turnaround quarter. Q4 FY2026 revenue rose 33% to $18.8 million with a return to GAAP profit, bookings hit a record $60.7 million and effective backlog topped $100.6 million. FY2027 guidance of $130-150 million implies 160-200% growth, so the post-earnings run prices in high expectations that depend on shipping FOX-XP systems on schedule without margin erosion. TRT is preferred for now. x.com  x.com 

Aehr Test Systems captures more value than Trio-Tech because it sells proprietary burn-in equipment, while Trio-Tech sells consumable boards that go into competing equipment. Aehr's FOX-XP is the only validated wafer-level burn-in solution for silicon photonics transceivers, with multiple AI optical I/O wins and a patent moat, so it captures any migration to wafer-level testing. Its Sonoma package-level system won a record $41M hyperscaler order, and H2 FY26 bookings topped $92M. x.com 

Aehr Test Systems is the cleaner AI burn-in play, with a structural edge in wafer-level burn-in that nobody else has and a $41M single order from a hyperscaler in April. Its roughly 25x premium to Trio-Tech reflects equipment margins and that moat, not mispricing. Trio-Tech grew revenue 69% but its services margin fell to about 16% as low-margin AI testing grew, and it raised equity 30-40% below market, so at $13 it looks fairly priced. x.com